Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma.

Rustad EH, Misund K, Bernard E, Coward E, Yellapantula VD, Hultcrantz M, Ho C, Kazandjian D, Korde N, Mailankody S, Keats JJ, Akhlaghi T, Viny AD, Mayman DJ, Carroll K, Patel M, Famulare CA, Op Bruinink DH, Hutt K, Jacobsen A, Huang Y, Miller JE, Maura F, Papaemmanuil E, Waage A, Arcila ME, Landgren O.

Am J Hematol. 2019 Oct 1. doi: 10.1002/ajh.25641. [Epub ahead of print]

PMID:
31571261
2.

MYC dysregulation in the progression of multiple myeloma.

Misund K, Keane N, Stein CK, Asmann YW, Day G, Welsh S, Van Wier SA, Riggs DL, Ahmann G, Chesi M, Viswanatha DS, Kumar SK, Dispenzieri A, Gonzalez-Calle V, Kyle RA, O'Dwyer M, Rajkumar SV, Kortüm KM, Keats JJ; MMRF CoMMpass Network, Fonseca R, Stewart AK, Kuehl WM, Braggio E, Bergsagel PL.

Leukemia. 2019 Aug 22. doi: 10.1038/s41375-019-0543-4. [Epub ahead of print] No abstract available.

PMID:
31439946
3.

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy.

Holien T, Misund K, Olsen OE, Baranowska KA, Buene G, Børset M, Waage A, Sundan A.

Oncotarget. 2018 Nov 13;9(89):36048. doi: 10.18632/oncotarget.26373. eCollection 2018 Nov 13.

4.

BMPR2 inhibits activin and BMP signaling via wild-type ALK2.

Olsen OE, Sankar M, Elsaadi S, Hella H, Buene G, Darvekar SR, Misund K, Katagiri T, Knaus P, Holien T.

J Cell Sci. 2018 Jun 11;131(11). pii: jcs213512. doi: 10.1242/jcs.213512.

5.

Anti-Cancer Potential of Homemade Fresh Garlic Extract Is Related to Increased Endoplasmic Reticulum Stress.

Petrovic V, Nepal A, Olaisen C, Bachke S, Hira J, Søgaard CK, Røst LM, Misund K, Andreassen T, Melø TM, Bartsova Z, Bruheim P, Otterlei M.

Nutrients. 2018 Apr 5;10(4). pii: E450. doi: 10.3390/nu10040450.

6.

Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss.

Zahoor M, Westhrin M, Aass KR, Moen SH, Misund K, Psonka-Antonczyk KM, Giliberto M, Buene G, Sundan A, Waage A, Sponaas AM, Standal T.

Blood Adv. 2017 Dec 13;1(27):2656-2666. doi: 10.1182/bloodadvances.2017010801. eCollection 2017 Dec 26.

7.

Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan™.

Tangen JM, Holien T, Mirlashari MR, Misund K, Hetland G.

Biomed Res Int. 2017;2017:2059825. doi: 10.1155/2017/2059825. Epub 2017 Nov 7.

8.

Monitoring multiple myeloma by quantification of recurrent mutations in serum.

Rustad EH, Coward E, Skytøen ER, Misund K, Holien T, Standal T, Børset M, Beisvag V, Myklebost O, Meza-Zepeda LA, Dai HY, Sundan A, Waage A.

Haematologica. 2017 Jul;102(7):1266-1272. doi: 10.3324/haematol.2016.160564. Epub 2017 Apr 6.

9.

Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3.

Abdollahi P, Vandsemb EN, Hjort MA, Misund K, Holien T, Sponaas AM, Rø TB, Slørdahl TS, Børset M.

Mol Cancer Res. 2017 Jan;15(1):69-77. doi: 10.1158/1541-7786.MCR-16-0212. Epub 2016 Oct 3.

10.

Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells.

Baranowska K, Misund K, Starheim KK, Holien T, Johansson I, Darvekar S, Buene G, Waage A, Bjørkøy G, Sundan A.

Oncotarget. 2016 Oct 25;7(43):70845-70856. doi: 10.18632/oncotarget.12226.

11.

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.

Våtsveen TK, Sponaas AM, Tian E, Zhang Q, Misund K, Sundan A, Børset M, Waage A, Brede G.

J Hematol Oncol. 2016 Aug 31;9(1):75. doi: 10.1186/s13045-016-0306-x.

12.

Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells.

Starheim KK, Holien T, Misund K, Johansson I, Baranowska KA, Sponaas AM, Hella H, Buene G, Waage A, Sundan A, Bjørkøy G.

Blood Cancer J. 2016 Jul 15;6(7):e446. doi: 10.1038/bcj.2016.56.

13.

The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.

Slørdahl TS, Abdollahi P, Vandsemb EN, Rampa C, Misund K, Baranowska KA, Westhrin M, Waage A, Rø TB, Børset M.

Oncotarget. 2016 May 10;7(19):27295-306. doi: 10.18632/oncotarget.8422.

14.

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids.

Wang H, Teriete P, Hu A, Raveendra-Panickar D, Pendelton K, Lazo JS, Eiseman J, Holien T, Misund K, Oliynyk G, Arsenian-Henriksson M, Cosford ND, Sundan A, Prochownik EV.

Oncotarget. 2015 Oct 20;6(32):32380-95. doi: 10.18632/oncotarget.6116.

15.

The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM.

Follin-Arbelet V, Misund K, Naderi EH, Ugland H, Sundan A, Blomhoff HK.

Sci Rep. 2015 Aug 26;5:13001. doi: 10.1038/srep13001.

16.

The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells.

Johansson I, Monsen VT, Pettersen K, Mildenberger J, Misund K, Kaarniranta K, Schønberg S, Bjørkøy G.

Autophagy. 2015;11(9):1636-51. doi: 10.1080/15548627.2015.1061170.

17.

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy.

Holien T, Misund K, Olsen OE, Baranowska KA, Buene G, Børset M, Waage A, Sundan A.

Oncotarget. 2015 Sep 8;6(26):22698-705. Erratum in: Oncotarget. 2018 Nov 13;9(89):36048.

18.

BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis.

Rustad EH, Dai HY, Hov H, Coward E, Beisvag V, Myklebost O, Hovig E, Nakken S, Vodák D, Meza-Zepeda LA, Sandvik AK, Wader KF, Misund K, Sundan A, Aarset H, Waage A.

Blood Cancer J. 2015 Mar 20;5:e299. doi: 10.1038/bcj.2015.24.

19.

Salt-inducible kinase 1 (SIK1) is induced by gastrin and inhibits migration of gastric adenocarcinoma cells.

Selvik LK, Rao S, Steigedal TS, Haltbakk I, Misund K, Bruland T, Prestvik WS, Lægreid A, Thommesen L.

PLoS One. 2014 Nov 10;9(11):e112485. doi: 10.1371/journal.pone.0112485. eCollection 2014.

20.

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.

Olsen OE, Wader KF, Misund K, Våtsveen TK, Rø TB, Mylin AK, Turesson I, Størdal BF, Moen SH, Standal T, Waage A, Sundan A, Holien T.

Blood Cancer J. 2014 Mar 21;4:e196. doi: 10.1038/bcj.2014.16.

21.

NR4A2 is regulated by gastrin and influences cellular responses of gastric adenocarcinoma cells.

Misund K, Selvik LK, Rao S, Nørsett K, Bakke I, Sandvik AK, Lægreid A, Bruland T, Prestvik WS, Thommesen L.

PLoS One. 2013 Sep 27;8(9):e76234. doi: 10.1371/journal.pone.0076234. eCollection 2013.

22.

Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells.

Müller R, Misund K, Holien T, Bachke S, Gilljam KM, Våtsveen TK, Rø TB, Bellacchio E, Sundan A, Otterlei M.

PLoS One. 2013 Jul 31;8(7):e70430. doi: 10.1371/journal.pone.0070430. Print 2013.

23.

Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.

Holien T, Olsen OE, Misund K, Hella H, Waage A, Rø TB, Sundan A.

Eur J Haematol. 2013 Oct;91(4):339-46. doi: 10.1111/ejh.12176. Epub 2013 Aug 20.

PMID:
23869695
24.

The duration of gastrin treatment affects global gene expression and molecular responses involved in ER stress and anti-apoptosis.

Selvik LK, Fjeldbo CS, Flatberg A, Steigedal TS, Misund K, Anderssen E, Doseth B, Langaas M, Tripathi S, Beisvag V, Lægreid A, Thommesen L, Bruland T.

BMC Genomics. 2013 Jun 28;14:429. doi: 10.1186/1471-2164-14-429.

25.

HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase.

Rø TB, Holien T, Fagerli UM, Hov H, Misund K, Waage A, Sundan A, Holt RU, Børset M.

Exp Hematol. 2013 Jul;41(7):646-55. doi: 10.1016/j.exphem.2013.03.002. Epub 2013 Mar 14.

PMID:
23499762
26.

Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK/STAT pathway.

Follin-Arbelet V, Torgersen ML, Naderi EH, Misund K, Sundan A, Blomhoff HK.

Cancer Lett. 2013 Jul 28;335(2):323-31. doi: 10.1016/j.canlet.2013.02.042. Epub 2013 Feb 26.

PMID:
23454584
27.

A method for measurement of drug sensitivity of myeloma cells co-cultured with bone marrow stromal cells.

Misund K, Baranowska KA, Holien T, Rampa C, Klein DC, Børset M, Waage A, Sundan A.

J Biomol Screen. 2013 Jul;18(6):637-46. doi: 10.1177/1087057113478168. Epub 2013 Feb 27.

PMID:
23446700
28.

Functional studies on RNA-transfected cell microarrays.

Fjeldbo CS, Misund K, Günther CC, Langaas M, Steigedal TS, Thommesen L, Laegreid A, Bruland T.

Methods Mol Biol. 2010;629:175-91. doi: 10.1007/978-1-60761-657-3_12.

PMID:
20387150
29.

Functional studies on transfected cell microarray analysed by linear regression modelling.

Fjeldbo CS, Misund K, Günther CC, Langaas M, Steigedal TS, Thommesen L, Laegreid A, Bruland T.

Nucleic Acids Res. 2008 Sep;36(15):e97. doi: 10.1093/nar/gkn428. Epub 2008 Jul 15.

30.

Inducible cAMP early repressor splice variants ICER I and IIgamma both repress transcription of c-fos and chromogranin A.

Misund K, Steigedal TS, Laegreid A, Thommesen L.

J Cell Biochem. 2007 Aug 15;101(6):1532-44.

PMID:
17340624
31.

Inducible cAMP early repressor suppresses gastrin-mediated activation of cyclin D1 and c-fos gene expression.

Steigedal TS, Bruland T, Misund K, Thommesen L, Laegreid A.

Am J Physiol Gastrointest Liver Physiol. 2007 Apr;292(4):G1062-9. Epub 2006 Dec 21.

Supplemental Content

Loading ...
Support Center